Barclays’s iShares US Medical Devices ETF IHI Stock Holding History

Barclays’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,000	Closed	-$703K	–	5070
2024 Q1	$703K	Hold	12,000	–	–	﹤0.01%	3369
2023 Q4	$648K	Buy	+12,000	New	+$586K	﹤0.01%	3718

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Barclays's IHI Position: Q2 2026 in Review

Barclays reduced its iShares US Medical Devices ETF (IHI) stake by 95% in Q2 2026, selling an estimated $4.9M and leaving 5,513 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #3539.

Barclays first reported a position in IHI in Q2 2013 and has held it in 35 quarters since. The position peaked at $61.9M in Q2 2021. 503 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Barclays held 5,513 shares of iShares US Medical Devices ETF worth $272K as of Q2 2026.
Barclays sold 96,432 iShares US Medical Devices ETF shares in Q2 2026, an estimated $4.9M.
iShares US Medical Devices ETF made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3539 holding.
Barclays first reported a position in iShares US Medical Devices ETF in Q2 2013 and has held it in 35 quarters since.
Barclays's iShares US Medical Devices ETF position peaked at $61.9M in Q2 2021.
503 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.